Mon panier

Jurkat/Human TRBV9 Stable Cell Line

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
CJUR-STP293-2Vials (1Vial X 2)
$4785.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

    1. Genetically modified cell lines best reflect MOA (Mechanism of Action)
    2. Higher activity and larger assay window for robust and reproducible cell-based bioassay
    3. Comprehensive application data to support assay development and validation
    4. Full tracible record, stringent quality control and validated cell passage stability
    5. Parental cell line legally obtained from internationally recognized cell resource bank and commercially licensed
    6. Global commercial license assistance whenever regulatory filing is required
  • Description

    The Jurkat/human TRBV9 Stable Cell Line was engineered to express the exogenous TCRβ chain harboring the human TRBV9 variable domain (NCBI: NG_001333.2) following knockout of the endogenous TCRβ chain. This reconstituted TRBV9-containing TCRβ chain pairs with the endogenous TCRα chain to reform the TCRαβ heterodimer, which subsequently assemble with the endogenous CD3 to enable cell surface expression of the TCR/CD3 complex. Surface expression of human TRBV9 was confirmed by flow cytometry. The endogenous TCRβ knockout was confirmed by genomic sequencing.

  • Application

    • Useful for cell-based TRBV9 binding assay

  • Growth Properties

    Suspension

  • Selection Marker

    Hygromycin B (20 μg/mL)

  • Complete Growth Medium

    RPMI-1640 + 10% FBS

  • Freeze Medium

    Serum-free cell cryopreservation medium

  • Quantity

    1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium

  • Storage

    Frozen in liquid nitrogen.

  • Mycoplasma Testing

    Negative

  • Sterility Testing

    Negative

  • Instructions for Use

    See data sheet for detailed culturing and assay protocol.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • Receptor Assay

     TRBV9 FACS

    Expression analysis of human TRBV9 on Jurkat/Human TRBV9 Stable Cell Line by FACS.
    Cell surface staining was performed on Jurkat/Human TRBV9 Stable Cell Line or negative control cell using anti-human TRBV9 antibody.

    Protocol
  •  TRBV9 FACS

    Expression analysis of human TCRαβ and human CD3 on Jurkat/Human TRBV9 Stable Cell Line by FACS.
    Cell surface staining was performed on Jurkat/Human TRBV9 Stable Cell Line using PE-labeled anti-human TCR αβ antibody and APC-labeled anti-human CD3 antibody. The Jurkat/Human TRBV9 Stable Cell Line was stained with PE-labeled isotype control antibody and APC-labeled isotype control antibody as the negative control cell. This result demonstrated the reconstituted TRBV9-containing TCRβ chain paired with the endogenous TCRα can assemble with the endogenous CD3 to enable cell surface expression of the TCR/CD3 complex.

    Protocol
  • Sequencing Analysis

     TRBV9 SEQUENCING_ANALYSIS

    Confirmation of endogenous human TCRβ knockout in the Jurkat/human TRBV9 Stable Cell Line.
    Sanger sequencing was used for mutation analysis of human TRBC. The sequencing results demonstrated that frameshift mutations were generated in the human TRBC gene in the Jurkat/Human TRBV9 Stable Cell Line.

*Please contact us if you are interested in related cell pool service.

Avis des utilisateurs
Publier un commentaire

Déclaration importante

  • Limited Use&License Disclosure

    BY USE OF THIS PRODUCT, RESEARCHER AGREES TO BE BOUND BY THE FOLLOWING TERMS OF LIMITED USE OF THIS CELL LINE PRODUCT.

    1. If the researcher is not willing to accept the terms of limited use of this cell line product, and the product is unused, ACRO will accept return of the unused product.
    2. Researchers may use this product for research use only, no commercial use is allowed. "Commercial use" means any and all uses of this product and derivatives by a party for profit or other consideration and may include but is not limited to use in: (1) product manufacture; and (2) to provide a service, information or data; and/or resale of the product or its derivatives, whether or not such product or derivatives are resold for use in research.
    3. This cell line is neither intended for any animal or human therapeutic purposes nor for any direct human in vivo use. You have no right to share, modify, transfer, distribute, sell, sublicense, or otherwise make the cell line available for use to other researchers, laboratories, research institutions, hospitals, universities, or service organizations.
    4. ACROBIOSYSTEMS MAKES NO WARRANTIES OR REPRESENTATIONS OF ANY KIND, EITHER EXPRESSED OR IMPLIED, WITH RESPECT TO THE SUITABILITY OF THE CELL LINE FOR ANY PARTICULAR USE.
    5. ACROBIOSYSTEMS ACCEPTS NO LIABILITY IN CONNECTION WITH THE HANDLING OR USE OF THE CELL LINE.
    6. Modifications of the cell line, transfer to a third party, or commercial use of the cell line may require a separate license and additional fees. Please contact order@acrobiosystems.com for further details.

Progrès de frontière

 
Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs
  • Déclaration importante